NM-002 (NovaBiotics)

N/A

Report date: 2025/12/12 16:59:19
NME

Base Information

Drug NameNM-002 (NovaBiotics)
Drug Alias NameCysteamine bitartrate (NovaBiotics)NM-002 (NovaBiotics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutathione synthase stimulants
TargetsGlutathione synthase
Therapy Area/IndicationsCommunity Acquired Pneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovabiotics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNovabiotics Ltd
Inactive CompaniesN/A
Active IndicationsCommunity Acquired Pneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A